S&P 500
(0.00%) 5 187.67 points
Dow Jones
(0.44%) 39 056 points
Nasdaq
(-0.18%) 16 303 points
Oil
(0.37%) $79.28
Gas
(-0.37%) $2.18
Gold
(-0.16%) $2 318.70
Silver
(0.25%) $27.67
Platinum
(0.27%) $987.30
USD/EUR
(0.04%) $0.930
USD/NOK
(0.08%) $10.90
USD/GBP
(0.02%) $0.800
USD/RUB
(0.00%) $91.74

リアルタイムの更新: FDC Limited [FDC.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
最終更新日時8 5月 2024 @ 18:59

1.03% INR 451.70

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts...

Stats
本日の出来高 97 215.00
平均出来高 178 915
時価総額 73.54B
EPS INR0 ( 2024-02-06 )
次の収益日 ( INR0 ) 2024-05-22
Last Dividend INR0.800 ( 2020-03-19 )
Next Dividend INR0 ( N/A )
P/E 25.43
ATR14 INR0.416 (0.09%)

ボリューム 相関

長: -0.03 (neutral)
短: -0.92 (very strong negative)
Signal:(34.513) Neutral

FDC Limited 相関

10 最も正の相関
KOTAKBANK.NS0.848
MAXVIL.NS0.806
10 最も負の相関
GANGOTRI.NS-0.83

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

FDC Limited 相関 - 通貨/商品

The country flag -0.28
( neutral )
The country flag -0.33
( neutral )
The country flag -0.11
( neutral )
The country flag -0.29
( neutral )
The country flag -0.67
( moderate negative )
The country flag -0.09
( neutral )

FDC Limited 財務諸表

Annual 2022
収益: INR17.84B
総利益: INR11.28B (63.24 %)
EPS: INR11.67
FY 2022
収益: INR17.84B
総利益: INR11.28B (63.24 %)
EPS: INR11.67
FY 2022
収益: INR15.26B
総利益: INR9.78B (64.12 %)
EPS: INR12.82
FY 2021
収益: INR13.27B
総利益: INR9.00B (67.82 %)
EPS: INR17.72

Financial Reports:

No articles found.

FDC Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

FDC Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.35 - low (44.58%) | Divividend Growth Potential Score: 4.24 - Potential for dividend initiation, but uncertain (15.16%)
Information
First Dividend INR0.100 2002-08-19
Last Dividend INR0.800 2020-03-19
Next Dividend INR0 N/A
Payout Date 2020-03-26
Next Payout Date N/A
# dividends 20 --
Total Paid Out INR24.83 --
Avg. Dividend % Per Year 0.03% --
Score 1.7 --
Div. Sustainability Score 4.35
Div.Growth Potential Score 4.24
Div. Directional Score 4.30 --
Next Divdend (Est)
(2024-09-06)
INR0 Estimate 0.00 %
Dividend Stability
0.05 Very Bad
Dividend Score
1.70
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2002 INR0 0.00%
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0.800 0.38%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SIYSIL.NS Dividend Junior 2023-07-24 Semi-Annually 18 1.37%
MEDICAMEQ.NS Ex Dividend Junior 2023-09-20 Annually 3 0.02%
GULFOILLUB.NS Dividend Junior 2023-08-25 Annually 11 2.19%
BBTC.NS Dividend Junior 2023-09-22 Annually 22 0.08%
PRESTIGE.NS Dividend Junior 2023-09-14 Annually 14 0.25%
KANSAINER.NS Dividend Junior 2023-05-25 Annually 21 0.49%
EIHAHOTELS.NS Dividend Junior 2023-07-31 Sporadic 17 0.31%
ADVENZYMES.NS Dividend Junior 2023-08-04 Annually 8 0.59%
SUBROS.NS Dividend Junior 2023-08-22 Annually 20 0.22%
NAHARSPING.NS Dividend Junior 2023-09-08 Annually 18 0.74%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1511.5006.9810.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1471.5009.4810.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM82.771.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM11.302.006.2310.00[0 - 30]
freeCashFlowPerShareTTM7.822.006.0910.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6571.0002.382.38[0.2 - 0.8]
operatingProfitMarginTTM0.1831.0008.348.34[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.35

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM24.961.0007.580[1 - 100]
returnOnEquityTTM0.1472.509.6710.00[0.1 - 1.5]
freeCashFlowPerShareTTM7.822.007.3910.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM11.302.006.2310.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.5061.5003.290[0.5 - 2]
operatingCashFlowSalesRatioTTM0.09601.000-0.09980[0.1 - 0.5]
Total Score4.24

FDC Limited

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。